Compare Siemens Healthineers AG with Similar Stocks
Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Operating profit has grown by an annual rate 12.09% of over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
EUR 40,337 Million ()
19.00
NA
2.80%
0.81
12.73%
2.19
Revenue and Profits:
Net Sales:
5,402 Million
(Quarterly Results - Dec 2025)
Net Profit:
456 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-31.15%
0%
-31.15%
6 Months
-33.18%
0%
-33.18%
1 Year
-34.74%
0%
-34.74%
2 Years
-31.68%
0%
-31.68%
3 Years
-32.12%
0%
-32.12%
4 Years
-24.84%
0%
-24.84%
5 Years
-16.84%
0%
-16.84%
Siemens Healthineers AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
9.58%
EBIT Growth (5y)
8.50%
EBIT to Interest (avg)
18.12
Debt to EBITDA (avg)
2.96
Net Debt to Equity (avg)
0.75
Sales to Capital Employed (avg)
0.62
Tax Ratio
24.22%
Dividend Payout Ratio
52.23%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
9.64%
ROE (avg)
11.15%
Valuation key factors
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
2.37
EV to EBIT
16.27
EV to EBITDA
11.83
EV to Capital Employed
1.83
EV to Sales
2.39
PEG Ratio
NA
Dividend Yield
2.58%
ROCE (Latest)
11.26%
ROE (Latest)
12.73%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 2 Foreign Institutions (0.01%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
5,402.00
5,482.00
-1.46%
Operating Profit (PBDIT) excl Other Income
1,022.00
1,036.00
-1.35%
Interest
96.00
108.00
-11.11%
Exceptional Items
-49.00
-33.00
-48.48%
Consolidate Net Profit
456.00
478.00
-4.60%
Operating Profit Margin (Excl OI)
134.00%
133.30%
0.07%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is -1.46% vs 5.91% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is -4.60% vs 10.65% in Dec 2024
Annual Results Snapshot (Consolidated) - Sep'25
Sep'25
Sep'24
Change(%)
Net Sales
23,375.00
22,363.00
4.53%
Operating Profit (PBDIT) excl Other Income
4,731.00
4,523.00
4.60%
Interest
425.00
476.00
-10.71%
Exceptional Items
-250.00
-431.00
42.00%
Consolidate Net Profit
2,168.00
1,959.00
10.67%
Operating Profit Margin (Excl OI)
147.00%
147.60%
-0.06%
USD in Million.
Net Sales
YoY Growth in year ended Sep 2025 is 4.53% vs 3.15% in Sep 2024
Consolidated Net Profit
YoY Growth in year ended Sep 2025 is 10.67% vs 28.46% in Sep 2024
About Siemens Healthineers AG 
Siemens Healthineers AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






